{
  "id": 1762,
  "text": "Vermorken et al.1667 found that the addition of bleomycin, vindesine, and mitomycin C to cisplatin had no impact in survival as compared to cisplatin alone in patients who had histologically confirmed advanced (FIGO stage IVB) or recurrent cervical cancer not suitable for curative treatment woth surgery and/or radiotherapy even if the combination regimen induced a significantly higher response rate than cisplatin alone ( $4 2 \\%$ versus $2 5 \\%$ $\\mathrm { p } = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Vermorken et al.1667 found that the addition of bleomycin, vindesine, and mitomycin C to cisplatin had no impact in survival as compared to cisplatin alone in patients who had histologically confirmed advanced (FIGO stage IVB) or recurrent cervical cancer not suitable for curative treatment woth surgery and/or radiotherapy even if the combination regimen induced a significantly higher response rat\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究显示，对于晚期或复发性宫颈癌患者，顺铂单药治疗与联合使用博来霉素、长春地辛和丝裂霉素C相比，在生存率方面没有显著差异。尽管联合治疗方案的反应率显著高于顺铂单药（42% 对比 25%），但这种差异并未转化为生存率的改善。因此，在这种情况下，顺铂单药治疗仍是一个合理的选择。",
  "query": "对于不能通过手术或放疗进行治愈性治疗的晚期或复发性宫颈癌患者，使用顺铂单药治疗与联合博来霉素、长春地辛和丝裂霉素C相比，是否在生存率方面有显著差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于不能通过手术或放疗进行治愈性治疗的晚期或复发性宫颈癌患者，使用顺铂单药治疗与联合博来霉素、长春地辛和丝裂霉素C相比，是否在生存率方面有显著差异？\n\n<reference text>: Vermorken et al.1667 found that the addition of bleomycin, vindesine, and mitomycin C to cisplatin had no impact in survival as compared to cisplatin alone in patients who had histologically confirmed advanced (FIGO stage IVB) or recurrent cervical cancer not suitable for curative treatment woth surgery and/or radiotherapy even if the combination regimen induced a significantly higher response rate than cisplatin alone ( $4 2 \\%$ versus $2 5 \\%$ $\\mathrm { p } = 0 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究显示，对于晚期或复发性宫颈癌患者，顺铂单药治疗与联合使用博来霉素、长春地辛和丝裂霉素C相比，在生存率方面没有显著差异。尽管联合治疗方案的反应率显著高于顺铂单药（42% 对比 25%），但这种差异并未转化为生存率的改善。因此，在这种情况下，顺铂单药治疗仍是一个合理的选择。"
}